{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:54:59Z","timestamp":1792713299703,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.semnephrol.2014.06.002","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T06:32:24Z","timestamp":1402641144000},"page":"351-364","source":"Crossref","is-referenced-by-count":7,"title":["Clinical Translation of Multipotent Mesenchymal Stromal Cells in Transplantation"],"prefix":"10.1016","volume":"34","author":[{"given":"Dani\u00eblle G.","family":"Leuning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies E.J.","family":"Reinders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes W.","family":"de Fijter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ton J.","family":"Rabelink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2014.06.002_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","article-title":"Chronic kidney disease","volume":"379","author":"Levey","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib2","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1681\/ASN.2012020164","article-title":"Lifetime risk of ESRD","volume":"23","author":"Turin","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","author":"Lamb","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib4","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1056\/NEJMcibr1112347","article-title":"Diabetic stem-cell \u201cmobilopathy.\u201d","volume":"365","author":"DiPersio","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib6","first-page":"83","article-title":"Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method","volume":"2","author":"Friedenstein","year":"1974","journal-title":"Exp Hematol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14653240500319234","article-title":"Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement","volume":"7","author":"Horwitz","year":"2005","journal-title":"Cytotherapy"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib8","first-page":"994","article-title":"Miro1 regulates intercellular mitochondrial transport and enhances mesenchymal stem cell rescue efficacy","volume":"33","author":"Ahmad","year":"2014","journal-title":"EMBO J"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A perivascular origin for mesenchymal stem cells in multiple human organs","volume":"3","author":"Crisan","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.scr.2011.08.003","article-title":"Comprehensive transcriptome and immunophenotype analysis of renal and cardiac MSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities","volume":"8","author":"Pelekanos","year":"2012","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib11","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1089\/scd.2008.0320","article-title":"Isolation and characterization of resident mesenchymal stem cells in human glomeruli","volume":"18","author":"Bruno","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib12","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1182\/blood-2003-05-1670","article-title":"Isolation of multipotent mesenchymal stem cells from umbilical cord blood","volume":"103","author":"Lee","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib13","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/01.tp.0000173794.72151.88","article-title":"Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp","volume":"80","author":"Pierdomenico","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib14","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1091\/mbc.E02-02-0105","article-title":"Human adipose tissue is a source of multipotent stem cells","volume":"13","author":"Zuk","year":"2002","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/stem.269","article-title":"Mesenchymal stromal cells: current understanding and clinical status","volume":"28","author":"Salem","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib16","doi-asserted-by":"crossref","first-page":"a015560","DOI":"10.1101\/cshperspect.a015560","article-title":"Mesenchymal stromal cells in transplantation rejection and tolerance","volume":"3","author":"English","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","article-title":"Mesenchymal stromal cells: sensors and switchers of inflammation","volume":"13","author":"Bernardo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib18","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/stem.1432","article-title":"Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages","volume":"31","author":"Melief","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide","volume":"2","author":"Ren","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.exphem.2009.01.005","article-title":"Mesenchymal stem cells suppress B-cell terminal differentiation","volume":"37","author":"Asari","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib21","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1002\/art.27560","article-title":"Interferon-gamma-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus","volume":"62","author":"Schena","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2249.2010.04158.x","article-title":"Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease","volume":"161","author":"Youd","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib23","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","article-title":"Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2","volume":"111","author":"Spaggiari","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm.3028","article-title":"The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine","volume":"19","author":"Bianco","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1681\/ASN.2009060615","article-title":"Distinct macrophage phenotypes contribute to kidney injury and repair","volume":"22","author":"Lee","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib26","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1172\/JCI60363","article-title":"CSF-1 signaling mediates recovery from acute kidney injury","volume":"122","author":"Zhang","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib27","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/cdd.2012.26","article-title":"Mesenchymal stem cells: a double-edged sword in regulating immune responses","volume":"19","author":"Li","year":"2012","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib28","doi-asserted-by":"crossref","first-page":"F901","DOI":"10.1152\/ajprenal.00542.2012","article-title":"Renal ischemia-reperfusion induces a dysbalance of angiopoietins, accompanied by proliferation of pericytes and fibrosis","volume":"305","author":"Khairoun","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib29","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib30","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.yexcr.2013.09.007","article-title":"Bone marrow-derived mesenchymal stem cells enhance angiogenesis via their alpha6beta1 integrin receptor","volume":"319","author":"Carrion","year":"2013","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2353\/ajpath.2010.090517","article-title":"Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis","volume":"176","author":"Humphreys","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/nep.12018","article-title":"Systematic review and meta-analysis of mesenchymal stem\/stromal cells therapy for impaired renal function in small animal models","volume":"18","author":"Wang","year":"2013","journal-title":"Nephrology"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib33","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/j.1600-6143.2012.04115.x","article-title":"Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation","volume":"12","author":"Casiraghi","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib34","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/TP.0b013e3181fed001","article-title":"Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression","volume":"90","author":"Ge","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib35","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1111\/j.1582-4934.2008.00641.x","article-title":"VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury","volume":"13","author":"Togel","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib36","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1681\/ASN.2006121318","article-title":"Insulin-like growth factor-1 sustains stem cell mediated renal repair","volume":"18","author":"Casiraghi","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib37","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1681\/ASN.2009030322","article-title":"Microvesicles from mesenchymal stromal cells protect against acute kidney injury","volume":"20","author":"Bonventre","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib38","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1089\/scd.2012.0266","article-title":"Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells","volume":"22","author":"Tomasoni","year":"2013","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib39","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1681\/ASN.2008070798","article-title":"Mesenchymal stem cell-derived microvesicles protect against acute tubular injury","volume":"20","author":"Bruno","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fimmu.2012.00297","article-title":"Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion","volume":"3","author":"Eggenhofer","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib42","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nm.3222","article-title":"MSCs: science and trials","volume":"19","author":"Fibbe","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib43","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa063842","article-title":"Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412","volume":"355","author":"Suntharalingam","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib44","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.1222878110","article-title":"Genomic responses in mouse models poorly mimic human inflammatory diseases","volume":"110","author":"Seok","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2215\/CJN.04950610","article-title":"Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility","volume":"6","author":"Perico","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib46","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/tri.12132","article-title":"Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation","volume":"26","author":"Perico","year":"2013","journal-title":"Transpl Int"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib47","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/jama.2012.316","article-title":"Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial","volume":"307","author":"Tan","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib48","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5966\/sctm.2012-0114","article-title":"Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study","volume":"2","author":"Reinders","year":"2013","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/TP.0b013e3182754c53","article-title":"Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study","volume":"95","author":"Peng","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib51","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1600-6143.2009.02721.x","article-title":"Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance","volume":"9","author":"Ge","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2047-1440-2-17","article-title":"Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study","volume":"2","author":"Streitz","year":"2013","journal-title":"Transpl Res"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib53","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.2174\/13816128113199990477","article-title":"Mesenchymal stromal cell therapy for cardio renal disorders","volume":"20","author":"Reinders","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib54","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3109\/14653249.2010.501788","article-title":"Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells","volume":"12","author":"Horn","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib55","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.4049\/jimmunol.181.6.3933","article-title":"Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells","volume":"181","author":"Horn","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib56","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","article-title":"Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo","volume":"30","author":"Bartholomew","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib57","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1016\/j.transproceed.2006.10.002","article-title":"Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft","volume":"38","author":"Zhou","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib58","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1089\/scd.2012.0096","article-title":"Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model","volume":"21","author":"Franquesa","year":"2012","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib59","article-title":"Human bone marrow-and adipose tissue-derived mesenchymal stromal cells are immunosuppressive in vitro and in a humanized allograft rejection model","volume":"Suppl 6","author":"Roemeling-van Rhijn","year":"2013","journal-title":"J Stem Cell Res Ther"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib60","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacc.2011.09.065","article-title":"First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction","volume":"59","author":"Houtgraaf","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib61","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12015-012-9418-z","article-title":"The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton\u2019s jelly of the human umbilical cord","volume":"9","author":"Bongso","year":"2013","journal-title":"Stem Cell Rev"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib62","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1474-9726.2008.00377.x","article-title":"Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts","volume":"7","author":"Zhou","year":"2008","journal-title":"Aging Cell"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib63","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fimmu.2012.00345","article-title":"Application of MultiStem((R)) allogeneic cells for immunomodulatory therapy: clinical progress and pre-clinical challenges in prophylaxis for graft versus host disease","volume":"3","author":"Vaes","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib64","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/icb.2012.67","article-title":"Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?","volume":"91","author":"Griffin","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib65","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fimmu.2012.00202","article-title":"Detrimental effects of rat mesenchymal stromal cell pre-treatment in a model of acute kidney rejection","volume":"3","author":"Seifert","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib66","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.tp.0000209919.90630.7b","article-title":"Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model","volume":"81","author":"Inoue","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib67","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/TP.0b013e31827d62e3","article-title":"Incidence and impact of de novo donor-specific alloantibody in primary renal allografts","volume":"95","author":"Everly","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib68","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrneph.2012.81","article-title":"The impact of donor-specific anti-HLA antibodies on late kidney allograft failure","volume":"8","author":"Loupy","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib69","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/TP.0b013e3182888db6","article-title":"The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes","volume":"95","author":"Freitas","year":"2013","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.semnephrol.2014.06.002_bib70","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jcyt.2013.01.010","article-title":"Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy","volume":"15","author":"Reinders","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib71","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/ki.2012.187","article-title":"Mesenchymal stem cells derived from adipose tissue are not affected by renal disease","volume":"82","author":"Roemeling-van Rhijn","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib72","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ndt\/gfr267","article-title":"Uremia induces functional incompetence of bone marrow-derived stromal cells","volume":"27","author":"Noh","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib73","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1161\/ATVBAHA.111.228601","article-title":"Exposure to uremic serum induces a procalcific phenotype in human mesenchymal stem cells","volume":"31","author":"Kramann","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib74","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib75","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1200\/JCO.2000.18.2.307","article-title":"Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy","volume":"18","author":"Koc","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib76","unstructured":"Available: www.clinicaltrials.gov. Accessed May 20, 2014"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib77","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib78","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1093\/eurheartj\/ehp265","article-title":"Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy","volume":"30","author":"Schuleri","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib79","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.113.300219","article-title":"Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions","volume":"113","author":"Sanganalmath","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib80","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/bjh.12545","article-title":"Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease","volume":"163","author":"Ball","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib81","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jcyt.2013.02.010","article-title":"Immunological characterization of multipotent mesenchymal stromal cells\u2013The International Society for Cellular Therapy (ISCT) working proposal","volume":"15","author":"Krampera","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib82","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood-2009-05-219907","article-title":"Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation","volume":"115","author":"Tarte","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib83","unstructured":"Available: www.ema.europa.eu. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/regulation\/general\/general_content_000295.jsp&mid=WC0b01ac058007f4bb; Accessed May 20, 2014."},{"key":"10.1016\/j.semnephrol.2014.06.002_bib84","unstructured":"Available: www.lonza.com. http:\/\/www.lonza.com\/about-lonza\/media-center\/news\/2013\/130220-ipsc-e.aspx; Accessed May 20, 2014."},{"key":"10.1016\/j.semnephrol.2014.06.002_bib85","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/ncb2872","article-title":"Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells","volume":"15","author":"Xia","year":"2013","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib86","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ncb2894","article-title":"Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney","volume":"16","author":"Takasato","year":"2014","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib87","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12035-011-8219-8","article-title":"Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington\u2019s disease","volume":"45","author":"Olson","year":"2012","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.semnephrol.2014.06.002_bib88","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.biomaterials.2013.11.019","article-title":"MSC-based VEGF gene therapy in rat myocardial infarction model using facial amphipathic bile acid-conjugated polyethyleneimine","volume":"35","author":"Moon","year":"2014","journal-title":"Biomaterials"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929514000758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929514000758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:24:34Z","timestamp":1649377474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929514000758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0270929514000758"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2014.06.002","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}